april 08, 2021

Liva Healthcare collaborates with consortium of EU bodies to provide innovative cardiac rehabilitation

Liva Healthcare, a European market leader in scalable digital health coaching, has announced its participation in a new partnership collaboration initiative to make cardiac rehabilitation accessible to more patients in the immediate aftermath of a heart attack. Liva Healthcare is part of a consortium of EU bodies led by Amgen, a worldwide pioneer in biotechnology, to co-create an innovative digital tele-rehabilitation solution called Rehab+.

The European Institute of Innovation and Technology (EIT) Health recently announced that Rehab+ has won a prestigious Education Award, which enables Rehab+ to be implemented in four rehabilitation centres across Spain and the Netherlands and evaluated by Maastricht University (Center for Cardiology Research). Based on the scientific evaluation, further uptake of Rehab+ in Netherlands, Spain and additional countries will be discussed.

Rehab+ supports patients for over one year, helping them to transition from a passive, recovery mindset into an active one of self-care. Rehab+ is designed to help individuals assess their lifestyle post-heart attack, set personal objectives to reduce their cardiac risk, and establish long-lasting positive lifestyle changes. Rehab+ supports and equips patients to stay engaged with their own health and to manage their cardiac risk factors as a chronic condition to prevent a next heart attack.

A consortium to future-proof cardiac rehabilitation

To develop Rehab+, Amgen collaborated with Liva Healthcare, rehabilitation hospitals in Spain, La Paz in Madrid, Vall d’Hebron in Barcelona, Virgen de la Victoria in Malaga and Zuyderland in the Netherlands. Amgen also partnered with regional payors in Spain, Servicio Madrileño de Salud (SERMAS), Servicio Andaluz de Salud (SAS) and Servicio Català de la Salut (Cat Salut), and Maastricht University in the Netherlands. Rehab+ is endorsed by Spanish Society of Cardiology (SEC), Netherlands Society of Cardiology (NVVC) and Foro Español de Pacientes (Spanish Patients Forum).

Liva Healthcare will provide the technology platform, including the patient app. Through the app, patients will have regular support from a professional human coach and receive educational content based on their personal needs and situation. Patients can also track their own progress real-time and engage with a support group of peers to keep them motivated.

Rehab+ is part of OPTIMISE, an Amgen-led cardiovascular programme which aims to transform patient care and demonstrate improvement in outcomes. This is achieved through a wide range of innovative initiatives which support the healthcare community and patients at high risk of cardiovascular disease.

Roman Stampfli, Vice President Marketing & Innovation at Amgen, says:

“Only a third of the one million people who have a heart attack each year in Europe have access to cardiac rehabilitation to reduce their risk of a second heart attack,” says Roman Stampfli, Vice President Marketing & Innovation at Amgen. “This consortium is part of our commitment to make cardiac rehabilitation accessible to more patients in the immediate aftermath of a heart attack. By collaborating with Liva Healthcare and the consortium of EU partners, we can co-create an innovative digital tele-rehab solution that helps people establish long-lasting lifestyle changes.”

André Sode, CEO of Liva Healthcare, says:

“Amgen is addressing a significant gap in cardiac recovery. We are delighted to collaborate with Amgen, and a powerful collective of purpose-driven organisations, to help improve the lives of people who have had a heart attack,” says André Sode, CEO of Liva Healthcare. “By combining our technology and the expertise of Amgen and the consortium of partners, we can make cardiac rehabilitation easily accessible to more people, empowering them to stay engaged with their own health and, ultimately, reduce their risk of a next heart attack.”


Jonas Damsgaard, Head of PR & Communications, jdj@livahealth.com

Related articles

Carl miljøbillede

september 29, 2022

Medstart indgår samarbejde med Liva Healthcare for at kombinere medicinsk behandling af overvægt med livsstilscoaching digitalt
Medstart, en nystartet digital lægeklinik der tilbyder vægttabsforløb, er gået sammen med den danske succeshistorie inden for digital sundhedscoaching, Liva Healthcare. Medstart vil på innovativ vis kombinere medicinsk behandling til appetitregulering med personlig livsstilscoaching via Liva-appen. Målsætningen er at skabe vedvarende vægttab hos brugerne. I maj indgik regeringen en bred politisk aftale om sundhedsreformen, som […]
Læs mere

september 20, 2022

Liva Health agrees exclusive rights to SMASH’s innovative offer platform and app
At Liva Health we’re dedicated to evolving the way we approach chronic diseases through safe, sustainable lifestyle changes delivered by digital health coaching. SMASH (Save Money And Stay Healthy) is tackling obesity by helping young people develop a better relationship with food through education and access to better-for-you food and drink options. We both understand […]
Læs mere
NHS logo

maj 29, 2022

Liva and LWTC to provide greater coverage and choice to participants as part of the successful NHS Diabetes Prevention Programme
Almost one million people have been referred to the NHS DPP since it launched in 2016, with participants who complete achieving an average weight loss of 3.3kg 29th May 2022 – In connection with the Type 2 Diabetes Prevention Week in the UK – a joint initiative between Diabetes UK and NHS England to raise […]
Læs mere
Sarah profilbillede

maj 16, 2022

Liva Healthcare appoints Sarah Beeby to lead growth in the UK market
Beeby is the first official UK Managing Director for the digital health coaching company Liva Healthcare (Liva), a European market leader in scalable digital health coaching, has appointed Sarah Beeby as Managing Director, UK. Sarah will be responsible for representing the UK market at board level and is a new member of the executive management team. In […]
Læs mere